Response to novelty after i.c.v. injection of melanin-concentrating hormone (MCH) in rats

Physiology and Behavior

Volumn 67, Issue 5, 1999, Pages 813-817

  Monzon M E ^a   De Barioglio, S R ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Elevated plus maze; MCH; Open field; Spatial novelty

Indexed keywords

MELANIN CONCENTRATING HORMONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HORMONE ACTION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LIGHT DARK CYCLE; MALE; MAZE TEST; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY;

EID: 0032739396     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(99)00117-1     Document Type: Article

References (40)

1. Beck P.E., Berger S.V., Sanvitto G.L., Lucion A.B. Effects of 6-hydroxydopamine on the open-field activity of stressed rats. Med. Sci. Res. 24:1996;743-744.
2. Bittencourt J.C., Presse F., Arias C., Peto C., Vaughan J., Nahon J.L., Vale W., Sawchenko P.E. The melanin-concentrating hormone system of rat brain. An immuno- and hybridization histochemical characterization J Comp. Neurol. 319:1992;218-245.
3. Breton C., Bahajaoui M., Roullon A., Bresson J.L., Fellman D., Bugnon C. Clonage d'un ADNc condant pour un neuropeptide apparenté à l'hormone de mélano concentration dans l'hypothalamus du rat. C.R. Soc. Biol. 183:1989;216-222.
4. Cerbone A., Sadile A.G. Behavioral habituation to spatial novelty. Interference and non-interference studies Neurosci. Biobehav. Rev. 18:1994;497-518.
5. Crusio W.E., Schwegler H. Hippocampal mossy fiber distribution covaries with open field habituation in the mouse. Behav. Brain. Res. 26:1987;153-158.
6. Dai H., Krost M., Corey R.J. A new methodological approach to the study of habituation. The use of positive and negative behavioral indices of habituation J. Neurosci. Method. 62:1995;169-174.
7. Ericson E., Samuelsson J., Ahlenius S. Photocell measurements of rats' motor activity. A contribution to sensitivity and validation in behavioural observation. J. Pharmacol. Methods. 62:1991;169-174.
8. Farambollini, F.; File, S. E.; Johnson, A. L.; Wilson, S. A.: An analysis of sex differences in the open field and test of exploration and anxiety. Abstract P184, Meeting of Br. Pharm. Soc., Dec. 1986.
9. File S.E., Wardill A.G. Validity of head-dipping as a measure of exploration in a modified hole-board. Psychopharmacology (Berlin). 44:1975;53-59.
10. Hamon M. Neuropharmacology of anxiety. Perspectives and prospects Trends Pharmacol. Sci. 15:1994;36-39.
11. Hervé C., Fellman D. Changes in rat melanin-concentrating hormone and dynorphin messenger ribonucleic acids induced by food deprivation. Neuropeptides. 31:1997;237-242.
12. Hogg S. A review of validity and variability of the elevated plus maze as an animal model of anxiety. Pharmacol. Biochem. Behav. 54:1996;21-30.
13. Hökfelt T. Neuropeptides in perspective. The last ten years Neuron. 7:1991;867.
14. Ivinskis I. The reliability of behavioural measures obtained in the open field. Aust. J. Psychol. 20:1986;173-177.
15. A receptor modulation of memory. The role of endogenous benzodiazepines Trends Pharmacol. Sci. 12:1991;260-265.
16. Izquierdo I., da Silva R.C., Bueno E., Silva M., Quillfeldt J.A., Medina J.H. Memory expression of habituation and of inhibitory avoidance is blocked by CNQX infused into entorhinal cortex. Behav. Neural Biol. 60:1993;5-8.
17. Kawauchi H., Kawazoe I., Tsubokawa M., Kishida M., Baker B.I. Characterization of melanin-concentrating hormone in chum salmon pituitaries. Nature. 305:1983;321-323.
18. Klinberg F., Klegel S. Lesions in four parts of the basal forebrain change basic behaviour in rats. Neuroreports. 4:1993;639-642.
19. Knigge K.M., Baxtergrillo D., Speciale J., Wagner J. Melanotropic peptides in the mammalian brain. The melanin concentrating hormone Peptide. 17:1996;1063-1073.
20. Köning J.R.F., Klippel R.A. The rat brain. A stereotaxic atlas:1963;Williams and Wilkins Co, Baltimore.
21. Krieger D.T. Brain peptides. What, where, and why? Science. 222:1983;975.
22. Lukaszewska I. Scopolamine impairs object exploration but not habituation in rats. Acta Neurobiol. Exp. 53:1993;243-250.
23. Nahon J.L., Presse F., Bittencourt J.C., Sawchenko P., Vale W. The rat melanin-concentrating hormone mRNA encodes multiple putative neuropeptides coexpressed in the dorsolateral hypothalamus. Endocrinology. 125:1989;2056-2065.
24. Nahon J.L., Presse F., Breton C., Hervieu G., Schorpp M. Structure and regulation of the melanin-concentrating hormone gene. Ann. NY Acad. Sci. 680:1993;111-129.
25. Nahon J.L., Presse F., Vaughan J., Fischer W., Bittencourt J., Hoeger C., Schoepfer C., Rivier J., Sawchenko P., Vale W. Characterization of mammalian melanin-concentrating hormones and their precursors. Casanueva F., Dieguez C. Recent advances in basic and clinical neuroendocrinology. 1989;15-23 Elsevier Science Publishers, B. V, Amsterdam, The Netherlands.
26. Pajot M.T., Presse F., Voko Z., Hoeger C., Mounier F., Epelbaum J., Nahon J.L. Neuropeptide-E-I antagonizes the action of melanin-concentrating hormone on stress-induced release of adrenocorticotropin in rat. J. Neuroendocrinol. 7:1995;297-303.
27. Parkes D.C. Diuretic and natriuretic actions of melanin-concentrating hormone in conscious sheep. J. Neuroendocrinol. 8:1996;57-63.
28. Pellow S., File S.E. Anxiolytic and anxiogenic drugs effects on exploratory activity in an elevated plus maze; A novel test of anxiety in rat. Pharmacol. Biochem. Behav. 24:1986;525-529.
29. Prescott R. Some behavioral effects of variables which influence general activity level. Anim. Behav. 18:1970;791-796.
30. Presse F., Nahon J.L. Differential regulation of melanin-concentrating hormone gene expression in distinct hypothalamic areas under osmotic stimulation in rats. Neuroscience. 55:1993;709-720.
31. Presse F., Hervieu G., Imaki T., Sawchenko P.E., Vale W., Nahon J.L. Melanin-concentrating hormone messenger ribonucleic acid expression. Marked changes during development and after stress and glucocorticoid stimuli Endocrinology. 131:1992;1241-1250.
32. Presse F., Nahon J.L., Fischer W.H., Vale W. Structure of the human melanin-concentrating hormone mRNA. Mol. Endocrinol. 4:1990;632-637.
33. Rovère C., Viale A., Nahon J.L., Kitabg L.P. Impaired processing of brain proneurotensin and promelanin-concentrating hormone in fat/fat mice. Endocrinology. 137:1996;2954-2958.
34. Sadile A.G., De Luca B., Cloffie L.A. Long term habituation to novel environment. Amnestic and hypermnemstic effects of various post-exposure treatments Abh. Akad. Wiss. DDR. 5:1978;203-218.
35. Skofitsch G., Jacobowitz D.M., Zamir N. Immunohistochemical localization of a melanin- concentrating hormone-like peptide in the rat brain. Brain Res. Bull. 15:1985;635-649.
36. Smith O.A., De Vito J.L. Central neural integration for the control of autonomic responses associated with emotion. Annu. Rev. Neurosci. 7:1984;43-65.
37. Thompson R.C., Watson S. Nucleotide sequence and tissue-specific expression of rat melanin-concentrating hormone gene. DNA Cell Biol. 9:1989;637-645.
38. Vaughan J., Fischer W., Hoeger C., Rivier J., Vale W. Characterization of melanin-concentrating hormones from rat hypothalamus. Endocrinology. 125:1989;1660-1665.
39. Walsh R.N., Cummins R.A. The open field test. A critical review Psychol. Bull. 83:1976;482-504.
40. Zamir N., Skofitsch G., Banon M.J., Jacobowitz D.M. Melanin-concentrating hormone. Unique peptide neuronal system in the rat brain and pituitary gland Proc. Natl. Acad. Sci. USA. 83:1986;1528-1531.